Results 11 to 20 of about 223,061 (328)

Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021

open access: yesEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022
Background Mycoplasma pneumoniae respiratory infections are transmitted by aerosol and droplets in close contact. Aim We investigated global M. pneumoniae incidence after implementation of non-pharmaceutical interventions (NPIs) against COVID-19 in March
P. M. Meyer Sauteur   +15 more
semanticscholar   +1 more source

Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development

open access: yesPathogens, 2021
Mycoplasma pneumoniae is a major causative agent of community-acquired pneumonia which can lead to both acute upper and lower respiratory tract inflammation, and extrapulmonary syndromes. Refractory pneumonia caused by M.
Zhulin Jiang   +4 more
semanticscholar   +1 more source

Atypical Pneumonia - Screening in a Tertiary Care Centre [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Introduction: Pneumonia is one of the leading infectious causes of mortality and morbidity worldwide. Atypical respiratory pathogens account for 30 – 40% of these infections.
Aruna Dorairaj   +2 more
doaj   +1 more source

Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value

open access: yesItalian Journal of Pediatrics, 2023
Background We investigated changes in microR-29c and microR-146a expression in the serum of children with Mycoplasma pneumoniae pneumonia, analysed their relationship with inflammatory factors and disease severity, and evaluated their diagnostic ...
Jingcai Wang   +4 more
doaj   +1 more source

Identification of Coinfections by Viral and Bacterial Pathogens in COVID-19 Hospitalized Patients in Peru: Molecular Diagnosis and Clinical Characteristics

open access: yesAntibiotics, 2021
The impact of respiratory coinfections in COVID-19 is still not well understood despite the growing evidence that consider coinfections greater than expected.
Giancarlo Pérez-Lazo   +13 more
doaj   +1 more source

Mycoplasma Pneumoniae-Induced Rash and Mucositis: A Systematic Review of the Literature

open access: yesSpartan Medical Research Journal, 2021
INTRODUCTION Mycoplasma pneumoniae (MP) is a common respiratory pathogen that can result in community-acquired pneumonia (CAP). Approximately 25% of patients diagnosed with MP experience extrapulmonary manifestations.
Daniel H Lofgren, Christopher P. Lenkeit
semanticscholar   +1 more source

Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia

open access: yesEmerging Infectious Diseases, 2020
A high prevalence rate of macrolide-resistant Mycoplasma pneumoniae (MRMP) has been reported in Asia. We performed a systematic review and meta-analysis to investigate the effect of macrolide resistance on the manifestations and clinical judgment during ...
Yu-Chin Chen   +2 more
semanticscholar   +1 more source

Multicenter Evaluation of the QIAstat-Dx Respiratory Panel for the Detection of Viruses and Bacteria in Nasopharyngeal Swab Specimens [PDF]

open access: yes, 2020
The QIAstat-Dx Respiratory Panel (QIAstat-Dx RP) is a multiplex in vitro diagnostic test for the qualitative detection of 20 pathogens directly from nasopharyngeal swab (NPS) specimens. The assay is performed using a simple sample-to-answer platform with
Granato, Paul   +8 more
core   +1 more source

COVID‐19 and mycoplasma pneumoniae coinfection

open access: yesAmerican journal of hematology/oncology, 2020
COVID-19 and mycoplasma pneumoniae coinfection Bingwen Eugene Fan | Kian Guan Eric Lim | Vanessa Cui Lian Chong | Stephrene Seok Wei Chan | Kiat Hoe Ong | Ponnudurai Kuperan Department of Haematology, Tan Tock Seng Hospital, Singapore Department of ...
B. Fan   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy